Osman R, L’Allier PL, Elgharib N, Tardif JC. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag. 2006;2(3):221–37. https://doi.org/10.2147/vhrm.s23221.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Habib SS, Kurdi MI, Al Aseri Z, Suriya MO. CRP levels are higher in patients with ST elevation than non-ST elevation acute coronary syndrome. Arq Bras Cardiol. 2011;96(1):13–7. https://doi.org/10.1590/S0066-782X2010005000161.

Article  CAS  PubMed  Google Scholar 

Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–43. https://doi.org/10.1161/hc0902.104353.

Article  CAS  PubMed  Google Scholar 

Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007;49(21):2129–38. https://doi.org/10.1016/j.jacc.2007.02.052.

Article  CAS  PubMed  Google Scholar 

Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med. 2006;145(1):21–9. https://doi.org/10.7326/0003-4819-145-1-200607040-00128.

Article  CAS  PubMed  Google Scholar 

Shemesh T, Rowley KG, Jenkins AJ, Best JD, O’Dea K. C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian aboriginal cohort. Clin Chem. 2099;55(2):336–41. https://doi.org/10.1373/clinchem.2008.115360.

Article  CAS  Google Scholar 

Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am JCardio. 1983;51(3):606. https://doi.org/10.1016/s0002-9149(83)80105-2.

Article  CAS  Google Scholar 

Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. JACC. 2014;64(24):e139–228. https://doi.org/10.1016/j.jacc.2014.09.017.

Article  PubMed  Google Scholar 

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction. Circulation. 2018;138(20):e618–51. https://doi.org/10.1016/j.jacc.2018.08.1038.

Article  PubMed  Google Scholar 

Thygesen K. Ten commandments’ for the Fourth Universal Definition of myocardial infarction 2018. Eur Heart J. 2019;40(3):226. https://doi.org/10.1093/eurheartj/ehy856.

Article  PubMed  Google Scholar 

Suleiman M, Aronson D, Reisner SA, Kapeliovich MR, Markiewicz W, Levy Y, et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med. 2003;115(9):695–701. https://doi.org/10.1016/j.amjmed.2003.06.008.

Article  CAS  PubMed  Google Scholar 

Foussas SG, Zairis MN, Lyras AG, Patsourakos NG, Tsirimpis VG, Katsaros K, et al. Early prognostic usefulness of C-reactive protein added to the Thrombolysis in myocardial infarction risk score in acute coronary syndromes. Am J C diol. 2005;96(4):533–7. https://doi.org/10.1016/j.amjcard.2005.04.015.

Article  CAS  Google Scholar 

Gautam AG, Bhatnagar M, Chauhan R. Sociodemographic and Clinical Profile of Coronary Artery Disease at a Tertiary Care Centre: a prospective study. IJSR. 2024;13(8):627–30. https://doi.org/10.21275/SR24713183601.

Article  Google Scholar 

Kappert K, Böhm M, Schmieder R, Schumacher H, Teo K, Yusuf S, et al. Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant subjects with Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan alone and in combination with Ramipril Global End Point Trial (ONTARGET). Circulation. 2012;126(8):934–41. https://doi.org/10.1161/CIRCULATIONAHA.111.086660.

Article  PubMed  Google Scholar 

Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, Dhandania VK, et al. Prevalence of dyslipidemia in urban and rural India: the ICMR–INDIAB study. PLoS ONE. 2014;9(5):e96808. https://doi.org/10.1371/journal.pone.0096808.

Article  CAS  PubMed  PubMed Central  Google Scholar 

González-Pacheco H, Vargas-Barrón J, Vallejo M, Piña-Reyna Y, Altamirano-Castillo A, Sánchez-Tapia P, et al. Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease. Ther Clin Risk Manag. 2014;10:815–23. https://doi.org/10.2147/TCRM.S67945.

Article  CAS  PubMed  PubMed Central  Google Scholar 

González-Pacheco H, Amezcua-Guerra LM, Vazquez-Rangel A, Martínez-Sánchez C, Pérez-Méndez O, Verdejo J, et al. Levels of high-density lipoprotein cholesterol are associated with biomarkers of inflammation in patients with acute coronary syndrome. Am J Cardiol. 2015;116(11):1651–7. https://doi.org/10.1016/j.amjcard.2015.09.009.

Article  CAS  PubMed  Google Scholar 

Njølstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation. 1996;93(3):450–6. https://doi.org/10.1161/01.CIR.93.3.450.

Article  PubMed  Google Scholar 

Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998;316(7137):1043–7. https://doi.org/10.1136/bmj.316.7137.1043.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta S, Gupta VK, Gupta R, Arora S, Gupta V. Relationship of high-sensitive C-reactive protein with cardiovascular risk factors, clinical presentation and angiographic profile in patients with acute coronary syndrome: an Indian perspective. Indian Heart J. 2013;65(3):359–65. https://doi.org/10.1016/j.ihj.2013.04.035.

Article  PubMed  PubMed Central  Google Scholar 

Othman AE. C-Reactive protein level could be a useful predictor of LV systolic dysfunction post myocardial infarction. Med J Cairo Univ. 2009;77(1):277–80.

Google Scholar 

Al Aseri ZA, Habib SS, Marzouk. Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction. Vasc Health Risk Manag. 2019;221–7. https://doi.org/10.2147/VHRM.S198452.

Jia EZ, Yang ZJ, Biao YU, Zang XL, Wang RH, Zhu TB, et al. Relationship between high sensitivity C-reactive protein level and angiographical characteristics of coronary atherosclerosis. Chin Med J (Engl). 2006;119(4):319–23. PMID: 16537028.

Article  CAS  PubMed  Google Scholar 

Peppes V, Rammos G, Manios E, Koroboki E, Rokas S, Zakopoulos N. Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and Gensini score: a hospital-based, prospective study in Greek patients. Clin Interv Aging. 2008;3(4):699–710. https://doi.org/10.2147/cia.s3551.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Auer J, Rammer M, Berent R, Weber T, Lassnig E, Eber B. Relation of CRP levels to the presence, extent and severity of angiographic coronary artery disease. Indian Heart J. 2002;54:284–8. PMID: 12216925.

CAS  PubMed  Google Scholar 

Raposeiras-Roubín S, Pardal CB, Janeiro BR, Abu-Assi E, García-Acuña JM, González-Juanatey JR. High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score. Angiology. 2012;63(1):30–4. https://doi.org/10.1177/0003319711406502.

Article  CAS  PubMed  Google Scholar 

McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in south Asian men with glucose intolerance and hyperinsulinemia. Circulation. 1993;87(1):152–61. https://doi.org/10.1161/01.CIR.87.1.152.

Article  CAS  PubMed  Google Scholar 

Beckles GL, Kirkwood BR, Carson DC, Miller GJ, Alexis SD, Byam NT. High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet. 1986;1(8493):1298–301. https://doi.org/10.1016/S0140-6736(86)91221-3.

Article  CAS  PubMed  Google Scholar 

Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ. 1991;302(6776):560–4. https://doi.org/10.1136/bmj.302.6776.560.

Article  CAS